Keyphrases
Valproic Acid
100%
Peroxisome Proliferator-activated Receptor
100%
In Vitro Techniques
100%
Teratogenic
100%
Embryotoxic Effect
100%
Viral
75%
VPA Derivatives
75%
Structure-activity Relationship
50%
Reporter Gene
50%
Teratogenic Effects
50%
Teratogen
50%
PPARD
50%
F9 Cells
50%
Cell Morphology
25%
Targeted Gene
25%
Berlin
25%
Specific Structure
25%
Stereoselectivity
25%
Acid Activation
25%
Acid Compounds
25%
Fatty Acids
25%
Structure-activity
25%
Animal Experiment
25%
CHO Cells
25%
Reporter Gene Assay
25%
Aliphatic Side Chain
25%
Stably Expressing
25%
Ligand-binding Domain
25%
Preclinical Development
25%
Induced Differentiation
25%
Teratogenicity
25%
Hybrid Protein
25%
Luciferase Gene
25%
Antiepileptic Drugs
25%
Neural Tube Defects
25%
Early Pregnancy
25%
Heptyl
25%
Pentenoic Acid
25%
New Antiepileptic Drugs
25%
Teratogenic Risk
25%
4-Pentynoic Acid
25%
Teratocarcinoma
25%
2-propyl-4
25%
ZEBET
25%
Propyl
25%
Morphology Induction
25%
Pharmacology, Toxicology and Pharmaceutical Science
Structure Activity Relationship
100%
Sodium Valproate
100%
Peroxisome Proliferator Activated Receptor
100%
Teratogenesis
100%
Anticonvulsive Agent
100%
Teratogenic Agent
100%
Peroxisome Proliferator Activated Receptor Delta
100%
Valproic Acid Derivative
100%
Teratogenicity
50%
2 Propyl 2 Pentenoic Acid
50%
Fatty Acid
50%
Peroxisome Proliferator Activated Receptor Alpha
50%
Peroxisome Proliferator Activated Receptor Gamma
50%
Neural Tube Defect
50%
Chimeric Protein
50%
Luciferase
50%
Teratocarcinoma
50%